Single cell chromatin accessibility reveals pancreatic islet cell type- and state-specific regulatory programs of diabetes risk
Joshua ChiouiD, Chun ZengiD, Cheng ZhangiD, Jee Yun HaniD, Michael Schlichting, Michael MilleriD, Robert Mendez, Serina HuangiD, Jinzhao WangiD, Yinghui Sui, Allison Deogaygay, Mei-Lin Okino, Yunjiang QiuiD, Ying SuniD, Parul KudtarkariD, Rongxin FangiD, Sebastian PreißliD, Maike SanderiD, David U. GorkiniD, Kyle J. GaultoniD
Abstract
Genetic risk variants for complex, multifactorial diseases are enriched in cis-regulatory elements. Single cell epigenomic technologies create new opportunities to dissect cell type-specific mechanisms of risk variants, yet this approach has not been widely applied to disease-relevant tissues. Given the central role of pancreatic islets in type 2 diabetes (T2D) pathophysiology, we generated accessible chromatin profiles from 14.2k islet cells and identified 13 cell clusters including multiple alpha, beta and delta cell clusters which represented hormone-producing and signal-responsive cell states. We cataloged 244,236 islet cell type accessible chromatin sites and identified transcription factors (TFs) underlying both lineage- and state-specific regulation. We measured the enrichment of T2D and glycemic trait GWAS for the accessible chromatin profiles of single cells, which revealed heterogeneity in the effects of beta cell states and TFs on fasting glucose and T2D risk. We further used machine learning to predict the cell type-specific regulatory function of genetic variants, and single cell co-accessibility to link distal sites to putative cell type-specific target genes. We localized 239 fine-mapped T2D risk signals to islet accessible chromatin, and further prioritized variants at these signals with predicted regulatory function and co-accessibility with target genes. At the KCNQ1 locus, the causal T2D variant rs231361 had predicted effects on an enhancer with beta cell-specific, long-range co-accessibility to the insulin promoter, and deletion of this enhancer reduced insulin gene and protein expression in human embryonic stem cell-derived beta cells. Our findings provide a cell type- and state-resolved map of gene regulation in human islets, illuminate likely mechanisms of T2D risk at hundreds of loci, and demonstrate the power of single cell epigenomics for interpreting complex disease genetics.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 189
- FWCI
- 29.80
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single cell multiome profiling of pancreatic islets reveals physiological changes in cell type-specific regulation associated with diabetes risk
Hannah M Mummey, Weston S. Elison, … Kyle J. Gaulton·bioRxiv·Aug 3, 2024
- Single-cell gene expression and chromatin accessibility profiling of human pancreatic islets at basal and stimulatory conditions nominates mechanisms of type 1 diabetes genetic risk
Ricardo D’Oliveira Albanus, Xuming Tang, … Stephen C.J. Parker·bioRxiv·Nov 12, 2022
- Genetic risk and inflammatory signaling converge on cell type-specific regulatory programs in type 1 diabetes
- Single cell ATAC-seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures
Vivek Rai, Daniel X. Quang, … Francis S. Collins·Molecular MetabolismPeer-reviewed·Dec 20, 2019
- Chromatin accessibility profiling uncovers genetic- and T2D disease state-associated changes in cis-regulatory element use in human islets
Shubham Khetan, Romy Kursawe, … Michael L. Stitzel·bioRxiv·Sep 22, 2017
- Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci
Matthias Thurner, Martijn van de Bunt, … Mark I. McCarthy·eLifePeer-reviewed·Feb 7, 2018